Lung Disease
Approximately 10,000 people are newly diagnosed with a lung condition each week and it is responsible for one million deaths and over six million in-patient hospital days per year.
Imperial College AHSC is the largest academic centre nationally for lung research bringing together the National Heart and Lung Institute and Imperial College Healthcare NHS Trust.
Our programmes cover the spectrum of respiratory disorders including commonly acquired conditions such as acute respiratory infections, asthma, chronic pulmonary obstructive disease, interstitial lung disease, tuberculosis and lung cancer, as well as rarer, genetic conditions such as cystic fibrosis.
Our thriving research portfolio is focused on developing new approaches to the detection and treatment of lung disease as well as targeted management strategies for chronic lung diseases, which can span the life course.
The partnership is home to the:
- MRC/PHE Centre for Environment and Health
- NIHR Health Protection Research Unit in Respiratory Infection
- Cystic Fibrosis Trust Strategic Research Centre on Pseudomonas Infection
- Cystic Fibrosis Trust Strategic Research Centre for targeting immunotherapy for fungal infection
- Cystic Fibrosis Trust Strategic Research Centre- EpiNet
- Imperial Air Quality Network
These centres are supporting research programmes into the prevention of lung diseases and early intervention. This focus is strengthened by the School of Public Health’s Environmental Research Group with its focus on air pollution.
